(Q33424057)

English

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)alpha agonist fenofibrate and the PPARgamma agonist pioglitazone

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)alpha agonist fenofibrate and the PPARgamma agonist pioglitazone (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Astrid K. Stunes

object named as

Astrid K Stunes

2

0 references

author name string

Unni Syversen

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Björn I Gustafsson

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Karl J Obrant

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Lars Nordsletten

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rolf Berge

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Liv Thommesen

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Janne E Reseland

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

30 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

BMC Endocrine Disorders

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Relationships between fat and bone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Skeletal consequences of thiazolidinedione therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

The effect of thiazolidinediones on adiponectin serum level: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Thiazolidinedione use and bone loss in older diabetic adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Nutrition-related peptides and bone homeostasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Short-term pioglitazone treatment prevents free fatty acid-induced hepatic insulin resistance in normal rats: possible role of the resistin and adiponectin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Stimulation of resorption in cultured mouse calvarial bones by thiazolidinediones

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Fenofibrate lowers adiposity and corrects metabolic abnormalities, but only partially restores endothelial function in dietary obese rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Enhanced bone formation in lipodystrophic PPARgamma(hyp/hyp) mice relocates haematopoiesis to the spleen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Bone is a target for the antidiabetic compound rosiglitazone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

The mechanisms of action of PPARs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Peroxisome proliferator-activated receptors: from genes to physiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Mechanism of action of fibrates on lipid and lipoprotein metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Peroxisome proliferator-activated receptors, orphans with ligands and functions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

21 June 2018

PPAR Tissue Distribution and Interactions with Other Hormone-Signaling Pathways

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-9-10

21 January 2018

Peroxisome proliterator-activated receptors, orphans with ligands and functions

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-9-10

21 January 2018

PPAR agonists amplify iNOS expression while inhibiting NF-kappaB: implications for mesangial cell activation by cytokines.

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-9-10

21 January 2018

Cloning and function of rabbit peroxisome proliferator-activated receptor delta/beta in mature osteoclasts

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-9-10

21 January 2018

Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-9-10

21 January 2018

Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone).

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-9-10

21 January 2018

Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-9-10

21 January 2018

Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-9-10

21 January 2018

Effects of PPARgamma and PPARalpha agonists on serum leptin levels in diet-induced obese rats

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-9-10

21 January 2018

Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-9-10

21 January 2018

Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-9-10

21 January 2018

PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-9-10

21 January 2018

Fenofibrate treatment is associated with better glycemic control and lower serum leptin and insulin levels in type 2 diabetic patients with hypertriglyceridemia.

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-9-10

21 January 2018

Serum adiponectin and bone mineral density in women.

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-9-10

21 January 2018

Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-9-10

21 January 2018

Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678137

31 October 2018

Effect of PPAR-γ Agonist on Adiponectin Levels in the Metabolic Syndrome: Lessons From the High Fructose Fed Rat Model

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-9-10

21 January 2018

Training increases the in vivo strength of the lower leg: an experimental study in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/19331671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of hypolipemic drugs on the osteoprotegerin - sRANKL system in patients with coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19331671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast

1 reference

https://pubmed.ncbi.nlm.nih.gov/19331671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men

1 reference

https://pubmed.ncbi.nlm.nih.gov/19331671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Muscle contraction increases the in vivo structural strength to the same degree in osteopenic and normal rat tibiae

1 reference

https://pubmed.ncbi.nlm.nih.gov/19331671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peroxisome proliferator-activated receptor activators modulate the osteoblastic maturation of MC3T3-E1 preosteoblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/19331671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of peroxisome proliferator-activated receptor-gamma pathway inhibits osteoclast differentiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19331671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PPAR agonists modulate human osteoclast formation and activity in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/19331671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1472-6823-9-10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33424057&oldid=2195349137"